GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cambridge Nutritional Sciences PLC (LSE:CNSL) » Definitions » 3-Year EPS without NRI Growth Rate

Cambridge Nutritional Sciences (LSE:CNSL) 3-Year EPS without NRI Growth Rate : 0.00% (As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Cambridge Nutritional Sciences 3-Year EPS without NRI Growth Rate?

Cambridge Nutritional Sciences's EPS without NRI for the six months ended in Sep. 2024 was £-0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Cambridge Nutritional Sciences was -8.20% per year. The lowest was -38.70% per year. And the median was -25.35% per year.


Competitive Comparison of Cambridge Nutritional Sciences's 3-Year EPS without NRI Growth Rate

For the Medical Instruments & Supplies subindustry, Cambridge Nutritional Sciences's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cambridge Nutritional Sciences's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cambridge Nutritional Sciences's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Cambridge Nutritional Sciences's 3-Year EPS without NRI Growth Rate falls into.


;
;

Cambridge Nutritional Sciences 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Cambridge Nutritional Sciences  (LSE:CNSL) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Cambridge Nutritional Sciences 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Cambridge Nutritional Sciences's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Cambridge Nutritional Sciences Business Description

Traded in Other Exchanges
N/A
Address
One Fleet Place, London, GBR, EC4M 7WS
Cambridge Nutritional Sciences PLC is a specialist medical diagnostics company focused on promoting a personalized and functional approach to health and nutrition. The group has two reportable segments: Health and Nutrition; and Corporate. The Health and Nutrition division specialises in the research, development, and production of kits to aid the detection of immune reactions to food. It also provides clinical analysis to the general public, clinics, and health professionals as well as supplying the point-of-care Food Detective test. The Corporate segment consists of centralised corporate costs which are not allocated to the trading activities of the group. The company generates the majority of its revenue from the Health and Nutrition segment.